Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sabina Frljak

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Cardiac Failure Review|April 11, 2022
Cell Therapy in Heart Failure with Preserved Ejection FractionSabina Frljak, Gregor Poglajen, Bojan Vrtovec
IEEE Transactions on Bio-Medical Engineering|August 9, 2013
Estimating the Universal Positions of Wireless Body Electrodes for Measuring Cardiac Electrical ActivityIvan Tomasić, Sabina Frljak, Roman Trobec
Cell Transplantation|March 23, 2022
Transendocardial CD34<sup>+</sup> Cell Therapy Improves Local Mechanical Dyssynchrony in Patients With Nonischemic Dilated CardiomyopathyNeža Žorž, Gregor Poglajen, Sabina Frljak, et al.
Stem Cells Translational Medicine|January 31, 2018
CD34<sup>+</sup> Cell Transplantation Improves Right Ventricular Function in Patients with Nonischemic Dilated CardiomyopathySabina Frljak, Martina Jaklic, Gregor Zemljic, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 17, 2012
Effect of cardiac resynchronization therapy on beat-to-beat T-wave amplitude variabilityDavid Žižek, Marta Cvijić, Jerneja Tasič, et al.
Mayo Clinic Proceedings|October 5, 2020
Larger End-Diastolic Volume Associates With Response to Cell Therapy in Patients With Nonischemic Dilated CardiomyopathySabina Frljak, Gregor Poglajen, Gregor Zemljic, et al.
Stem Cells International|March 15, 2018
Stem Cell Therapy in Patients with Chronic Nonischemic Heart FailureGregor Poglajen, Gregor Zemljič, Sabina Frljak, et al.
Cell Transplantation|May 4, 2019
Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart FailureGregor Poglajen, Gregor Zemljič, Andraž Cerar, et al.
Current Heart Failure Reports|August 13, 2020
Stem Cell Therapy for Chronic and Advanced Heart FailureGregor Poglajen, Sabina Frljak, Gregor Zemljič, et al.
Disease Markers|December 31, 2019
Favorable Response to CD34+ Cell Therapy Is Associated with a Decrease of Galectin-3 Levels in Patients with Chronic Heart FailureGregor Poglajen, Jus Ksela, Sabina Frljak, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Cardiac Failure Review|April 11, 2022
Cell Therapy in Heart Failure with Preserved Ejection FractionSabina Frljak, Gregor Poglajen, Bojan Vrtovec
IEEE Transactions on Bio-Medical Engineering|August 9, 2013
Estimating the Universal Positions of Wireless Body Electrodes for Measuring Cardiac Electrical ActivityIvan Tomasić, Sabina Frljak, Roman Trobec
Cell Transplantation|March 23, 2022
Transendocardial CD34<sup>+</sup> Cell Therapy Improves Local Mechanical Dyssynchrony in Patients With Nonischemic Dilated CardiomyopathyNeža Žorž, Gregor Poglajen, Sabina Frljak, et al.
Stem Cells Translational Medicine|January 31, 2018
CD34<sup>+</sup> Cell Transplantation Improves Right Ventricular Function in Patients with Nonischemic Dilated CardiomyopathySabina Frljak, Martina Jaklic, Gregor Zemljic, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 17, 2012
Effect of cardiac resynchronization therapy on beat-to-beat T-wave amplitude variabilityDavid Žižek, Marta Cvijić, Jerneja Tasič, et al.
Mayo Clinic Proceedings|October 5, 2020
Larger End-Diastolic Volume Associates With Response to Cell Therapy in Patients With Nonischemic Dilated CardiomyopathySabina Frljak, Gregor Poglajen, Gregor Zemljic, et al.
Stem Cells International|March 15, 2018
Stem Cell Therapy in Patients with Chronic Nonischemic Heart FailureGregor Poglajen, Gregor Zemljič, Sabina Frljak, et al.
Cell Transplantation|May 4, 2019
Transendocardial CD34+ Cell Therapy does not Increase the Risk of Ventricular Arrhythmias in Patients with Chronic Heart FailureGregor Poglajen, Gregor Zemljič, Andraž Cerar, et al.
Current Heart Failure Reports|August 13, 2020
Stem Cell Therapy for Chronic and Advanced Heart FailureGregor Poglajen, Sabina Frljak, Gregor Zemljič, et al.
Disease Markers|December 31, 2019
Favorable Response to CD34+ Cell Therapy Is Associated with a Decrease of Galectin-3 Levels in Patients with Chronic Heart FailureGregor Poglajen, Jus Ksela, Sabina Frljak, et al.
Pageof 3